No DOAC was taken on certain days (shaded) and on the day of the elective surgery or procedure. The light blue arrows refer to an exception to the basic management, a subgroup of patients taking dabigatran with a creatinine clearance (C-CI) less than 50 ng/mi. The orange arrows refer to patients having a high-bleed-risk surgical procedure. Dark blue arrows refer to patients having a low-bleed-risk surgical procedure. The thickened orange part of the arrows refer to flexibility in the timing of DOAC resumption after a procedure. *Cancer diagnosed within 3 months or has been treated within 6 months or metastatic.

No DOAC was taken on certain days (shaded) and on the day of the elective surgery or procedure. The light blue arrows refer to an exception to the basic management, a subgroup of patients taking dabigatran with a creatinine clearance (C-CI) less than 50 ng/mi. The orange arrows refer to patients having a high-bleed-risk surgical procedure. Dark blue arrows refer to patients having a low-bleed-risk surgical procedure. The thickened orange part of the arrows refer to flexibility in the timing of DOAC resumption after a procedure. *Cancer diagnosed within 3 months or has been treated within 6 months or metastatic.

Close Modal

or Create an Account

Close Modal
Close Modal